EXPRESS SCRIPTS ALERT: J&W Announces Investigation of Express Scripts; Expects to Lose Biggest Customer, Investors Encouraged to Contact Firm
SAN DIEGO, April 24, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Express Scripts Holding Company (NASDAQ: ESRX) and certain of its officers. Express Scripts operates as a pharmacy benefit management (PBM) company in the United States, Canada, and Europe.
On April 24, 2017, Express Scripts shares fell over 15% in after-hours trading when the Company announced that it is losing its biggest customer, Anthem Inc. Anthem accounted for about 18 percent of Express Scripts' first-quarter revenue in 2017.
Anthem filed a lawsuit against Express Scripts over drug prices claiming of being overcharged.
If you have information that could assist in this investigation, including former employees and others, or if you are an Express Scripts shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker ([email protected]) by email or by phone at 619-814-4471. If you email, please include your phone number.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Contact:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
[email protected]
SOURCE Johnson & Weaver, LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article